ISSN 2149-2263 | E-ISSN 2149-2271
pdf
Clinical implications from the European Heart Rhythm Association consensus document on antiarrhythmic drug therapy [Anatol J Cardiol]
Anatol J Cardiol. 2018; 20(1): 48-51 | DOI: 10.14744/AnatolJCardiol.2018.03285

Clinical implications from the European Heart Rhythm Association consensus document on antiarrhythmic drug therapy

Emin Evren Özcan1, Bülent Görenek2
1Department of Cardiology, Faculty of Medicine, Dokuz Eylül University; İzmir-Turkey
2Department of Cardiology, Faculty of Medicine, Eskişehir Osmangazi University; Eskişehir-Turkey

The recently published consensus document by the European Heart Rhythm Association presents a patient-tailored pharmacological antiarrhythmic treatment approach targeting the arrhythmia mechanism. This document comprehensively reviews the indications, side effects, and contraindications of antiarrhythmic drugs. In this paper, we reviewed novel treatment concepts offered by the consensus document.

Keywords: antiarrhythmic drugs, pharmacological antiarrhythmic therapy, proarrhythmia, pharmacokinetics, pharmacodynamics

Emin Evren Özcan, Bülent Görenek. Clinical implications from the European Heart Rhythm Association consensus document on antiarrhythmic drug therapy. Anatol J Cardiol. 2018; 20(1): 48-51

Corresponding Author: Bülent Görenek, Türkiye
Manuscript Language: English


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2024 The Anatolian Journal of Cardiology



Kare Publishing is a subsidiary of Kare Media.